The goal of this study was to understand the role of the HER2 pathway as a mechanism of the cytotoxic and migration-inhibitory effect of brazilin and the combination of brazilin with doxorubicin on HER2 breast cancer cells (MCF-7/HER2). This evidence concerns the gene ERBB2 and breast cancer.